Results 261 to 270 of about 26,068 (276)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease

British Journal of Pharmacology, 2022
Ulrich Kintscher, George Bakris, Peter Kolkhof   +2 more
exaly  

Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

Kidney International Supplements, 2022
Toshifumi Nakamura, Sophie Girerd, Frederic Jaisser   +2 more
exaly  

Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care

European Journal of Heart Failure, 2021
Marco Trevisan, Edouard L Fu, Yang Xu
exaly  

Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys

Annual Review of Medicine, 2023
Jordana B Cohen, Msce, Irina Bancos, Jenifer M Brown   +2 more
exaly  

Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics

Expert Opinion on Investigational Drugs, 2021
Jonatan Barrera-Chimal, Peter Kolkhof, Ixchel Lima Posada   +2 more
exaly  

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Journal of the American College of Cardiology, 2021
João Pedro Ferreira, Stuart J Pocock, Stefan D Anker   +2 more
exaly  

Mineralocorticoid receptor antagonists

2018
openaire   +1 more source

Mineralocorticoid Receptor Antagonists

2005
openaire   +1 more source

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

European Journal of Heart Failure, 2018
Gianluigi Savarese, Bertram Pitt, Stefan D Anker   +2 more
exaly